These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2255080)
21. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466 [TBL] [Abstract][Full Text] [Related]
22. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis. Richards CA; Short SA; Thorgeirsson SS; Huber BE Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325 [TBL] [Abstract][Full Text] [Related]
23. N-ras mutation in chemically induced rat brain tumour. Rády P; Kinsella AR; Fox M; Arany I; Kertai P Acta Biochim Biophys Hung; 1989; 24(4):313-6. PubMed ID: 2577259 [TBL] [Abstract][Full Text] [Related]
24. Oncogenes in head and neck cancer. Irish JC; Bernstein A Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418 [TBL] [Abstract][Full Text] [Related]
26. Amplification and activation of c-Ki-ras oncogene in cell line developed from human pancreas explants. Maheshwari KK; Parsa I Biochem Int; 1991 Sep; 25(2):233-40. PubMed ID: 1789790 [TBL] [Abstract][Full Text] [Related]
31. The detection of chemically initiated cells having the mutation of K-ras gene at an early stage of lung carcinogenesis in mice. Yano T; Yuasa M; Murakami A; Ichikawa T; Hagiwara K Anal Biochem; 1997 Jan; 244(1):187-9. PubMed ID: 9025932 [No Abstract] [Full Text] [Related]
33. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma]. Bian M; Fan Q; Huang S Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576 [TBL] [Abstract][Full Text] [Related]
34. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Calabretta B Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794 [No Abstract] [Full Text] [Related]
36. [Polymerase chain reaction (PCR)--a novel tool for the molecular diagnosis of neoplasms]. Yokota S; Abe T Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1395-401. PubMed ID: 2202261 [TBL] [Abstract][Full Text] [Related]
37. [DNA probes in the characterization of solid tumors]. Pierotti MA Minerva Med; 1992 Jun; 83(6):323-31. PubMed ID: 1321368 [No Abstract] [Full Text] [Related]
38. [The relationship between oncogenes and chromosome abnormalities in the pathogenesis and progression of lung cancer]. Yokota J; Wada M; Sugimura T; Terada M Gan No Rinsho; 1989 May; Spec No():157-63. PubMed ID: 2689660 [No Abstract] [Full Text] [Related]
39. Molecular alterations in human skin tumors. Ananthaswamy HN; Pierceall WE Prog Clin Biol Res; 1992; 376():61-84. PubMed ID: 1528930 [TBL] [Abstract][Full Text] [Related]